Galderma has filed a patent for compositions and methods aimed at promoting healthy skin, skin regeneration, repair, and wound healing. The invention focuses on skincare treatment, offering innovative solutions for enhancing skin health and healing processes. GlobalData’s report on Galderma gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Galderma SA - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Galderma, Nanoemulsion cosmetics was a key innovation area identified from patents. Galderma's grant share as of January 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents.

Skincare treatment compositions and methods

Source: United States Patent and Trademark Office (USPTO). Credit: Galderma SA

The patent application (Publication Number: US20240016880A1) discloses a topical composition designed for skin application, particularly around the eye area. The composition includes specific peptides such as tripeptide-1 and hexapeptide-12 at defined concentrations ranging from 0.5-100 ppm. These peptides, along with a tetrapeptide and various excipients like caprylic/capric triglyceride and niacinamide, aim to promote skin restoration and brightening around the eyes. The formulation is in the form of a cream and can contain additional peptides like palmitoyl tetrapeptide-7, functionalized with palmitoyl or myristoyl groups, to enhance its efficacy.

Moreover, the topical composition can be customized with different amino acid sequences for the tetrapeptide, such as GQPR, KTFK, AQTR, or RSRK, with a preference for GQPR. The inclusion of specific excipients like cydopeniasiioxane and tocopherol further enhances the formulation's skin benefits. The patent highlights the potential of this composition to address skin concerns specific to the delicate eye area, offering a comprehensive solution for skin restoration and brightening. The precise concentrations of peptides and the selection of excipients underscore the formulation's efficacy and safety for topical application, positioning it as a promising product in the skincare industry.

To know more about GlobalData’s detailed insights on Galderma, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies